SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-24-012051
Filing Date
2024-08-13
Accepted
2024-08-13 16:01:27
Documents
72
Period of Report
2024-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q tmb-20240630x10q.htm   iXBRL 10-Q 2083393
2 EX-31.1 tmb-20240630xex31d1.htm EX-31.1 16509
3 EX-31.2 tmb-20240630xex31d2.htm EX-31.2 13474
4 EX-32.1 tmb-20240630xex32d1.htm EX-32.1 7663
5 EX-32.2 tmb-20240630xex32d2.htm EX-32.2 6976
  Complete submission text file 0001558370-24-012051.txt   7349874

Data Files

Seq Description Document Type Size
6 EX-101.SCH tmb-20240630.xsd EX-101.SCH 58636
7 EX-101.CAL tmb-20240630_cal.xml EX-101.CAL 47071
8 EX-101.DEF tmb-20240630_def.xml EX-101.DEF 256091
9 EX-101.LAB tmb-20240630_lab.xml EX-101.LAB 394292
10 EX-101.PRE tmb-20240630_pre.xml EX-101.PRE 358159
75 EXTRACTED XBRL INSTANCE DOCUMENT tmb-20240630x10q_htm.xml XML 1074682
Mailing Address 377 PLANTATION STREET WORCESTER MA 01605
Business Address 377 PLANTATION STREET WORCESTER MA 01605 7816524500
MUSTANG BIO, INC. (Filer) CIK: 0001680048 (see all company filings)

IRS No.: 473828760 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38191 | Film No.: 241201232
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)